Calcium based binders can be used as the initial binder therapy in CKD patients but are not the preferred option in case of hypercalcemia and/or when plasma PTH concentrations are < 150 pg/mL on two consecutive blood tests [75]. This evidence concerns the gene PTH and chronic kidney disease.